Pharmaceuticals

Reports by Industry

Research Reports in Pharmaceuticals

Multiple Sclerosis – Drug Pipeline Landscape, 2023
February, 2023

Multiple Sclerosis (MS) is an autoimmune disorder in which the immune system attacks the myelin sheath that surrounds and protects the nerve fibers, causing inflammation eventually affecting the brain, spinal cord and optic nerves which disrupts the flow of information… Read More
Single User License
Buy Now

Digital Genome Market 
February, 2023

The global Digital Genome Market was valued at USD 28.2 Billion in 2022 and it is anticipated to grow up to USD 64.6 Billion by 2032, at a CAGR of 8.6% during the forecast period. Deep learning is a subset… Read More
Single User License
Buy Now

Gaucher’s Disease – Drug Pipeline Landscape, 2023
February, 2023

Gaucher's disease, or Gaucher disease (GD), is an inherited genetic disorder of the lysosomal storage that is caused by a genetic defect of the lysosomal enzyme "glucocerebrosidase." This enzyme accumulates in cells and certain organs, including the spleen and liver.… Read More
Single User License
Buy Now

Attention Deficit Hyperactivity Disorder (ADHD) – Drug Pipeline Landscape, 2023
February, 2023

Attention Deficit Hyperactivity Disorder (ADHD) is a mental health condition that can cause unusual levels of hyperactivity and impulsive behaviours. People with ADHD may also have trouble focusing their attention on a single task or sitting still for long periods… Read More
Single User License
Buy Now

RNAi Therapeutics Market 
February, 2023

The global RNAi Therapeutics Market was valued at USD 1.4 Billion in 2021 and it is anticipated to grow up to USD 3.8 Billion by 2031, at a CAGR of 10.4% during the forecast period. A brand-new class of drugs… Read More
Single User License
Buy Now

Chemotherapy Induced Neutropenia (CIN) – Drug Pipeline Landscape, 2023
February, 2023

Chemotherapy Induced Neutropenia is a very common side effect of cancer treatment in which the number of neutrophils in the blood drops below a healthy level. Chemotherapy Induced Neutropenia main causes are age, co-morbidities, and time course of therapy. Chemotherapy… Read More
Single User License
Buy Now

Medical Enzyme Technology Market 
January, 2023

The global Medical Enzyme Technology market was valued at USD 3.9 Billion in 2022 and it is anticipated to grow up to USD 7.7 Billion by 2032, at a CAGR of 7.0% during the forecast period. Enzymes play a crucial… Read More
Single User License
Buy Now

Cell Culture Media Market
January, 2023

The global Cell Culture Media Market was valued at 4.2 billion in 2022 and it is anticipated to grow up to USD 12.7 billion by 2032, at a CAGR of 11.7% during the forecast period. Cell culture media is a… Read More
Single User License
Buy Now

Long Read Sequencing Market 
January, 2023

The global Long Read Sequencing Market was valued at 1.5 billion in 2022 and it is anticipated to grow up to USD 6.0 billion by 2032, at a CAGR of 14.8% during the forecast period. DNS is the Domain Name… Read More
Single User License
Buy Now

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
January, 2023

The global small intestinal bacterial overgrowth diagnostics market was valued at USD 1,38,324.2 Thousand in 2022 and it is anticipated to grow up to USD 2,44,337.1 Thousand by 2032, at a CAGR of 5.9% during the forecast period. Small intestinal… Read More
Single User License
Buy Now

Histopathology Services Market 
January, 2023

The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period. Histopathology services are used in… Read More
Single User License
Buy Now

Biopreservation Market
January, 2023

The global Biopreservation Market was valued at USD 2.2 Billion in 2022 and it is anticipated to grow up to USD 26.7 Billion by 2032, at a CAGR of 28.5% during the forecast period. Bio-preservative is a technique for preserving… Read More
Single User License
Buy Now

Blood Brain Barrier Technologies Market
January, 2023

The global Blood-Brain Barrier Technologies Market was valued at USD 4.8 Billion in 2022 and it is anticipated to grow up to USD 9.9 Billion by 2032, at a CAGR of 7.5% during the forecast period. Blood-brain barrier (BBB) is… Read More
Single User License
Buy Now

Paroxysmal Nocturnal Hemoglobinuria (PNH) – Drug Pipeline Landscape, 2023
January, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare disease in which red blood cells break down earlier than normal. Paroxysmal Nocturnal Hemoglobinuria main causes are age, obesity and hormone therapy, and a genetic disorder. Paroxysmal Nocturnal Hemoglobinuria symptoms includes abdominal pain,… Read More
Single User License
Buy Now

Virus-Like Particles Market 
January, 2023

The global Virus-Like Particles (VLP’s) Market was valued at USD 4.6 Billion in 2022 and it is anticipated to grow up to USD 8.9 Billion by 2032, at a CAGR of 6.8% during the forecast period. Virus-like particles (VLPs) are… Read More
Single User License
Buy Now

Metabolomics Services Market 
January, 2023

The global Metabolomics Services market was valued at USD 6.3 Billion in 2022 and it is anticipated to grow up to USD 19.1 Billion by 2032, at a CAGR of 11.8% during the forecast period. Metabolomics is an objective lens… Read More
Single User License
Buy Now

Asthma – Drug Pipeline Landscape, 2023
January, 2023

Asthma is a chronic inflammatory disease of the lungs. The airways in the lungs become narrow due to inflammation and tightening of the muscles around the small airways and also due to excess mucus. It is characterized by airflow obstruction… Read More
Single User License
Buy Now

Gastroesophageal Reflux Disease (GERD) – Drug Pipeline Landscape, 2023
January, 2023

Gastroesophageal Reflux Disease (GERD) or acid reflux is a condition in which the content of the stomach regurgitates (backs up, or refluxes) into the esophagus. The refluxate is usually acidic and can cause inflammation and erosions. Gastroesophageal reflux disease can… Read More
Single User License
Buy Now

Low Molecular Weight Heparin Market 
January, 2023

The global Low Molecular Weight Heparin Market was valued at 3.8 billion in 2022 and it is anticipated to grow up to USD 8.5 billion by 2032, at a CAGR of 8.4% during the forecast period. Low molecular weight heparin… Read More
Single User License
Buy Now

Endocrine Testing Market
January, 2023

The global Endocrine Testing Market was valued at USD 2.5 Billion in 2022 and it is anticipated to grow up to USD 8.8 Billion by 2032, at a CAGR of 13.5% during the forecast period. Endocrine testing refers to the… Read More
Single User License
Buy Now

Frozen Tissues Samples Market
January, 2023

The global Frozen Tissue Samples Market was valued at USD 44.4 Million in 2022 and it is anticipated to grow up to USD 151.3 Million by 2032, at a CAGR of 13.0% during the forecast period. Frozen tissues samples play… Read More
Single User License
Buy Now

Disposable Pipette Tips Market
January, 2023

The global Disposable Pipette Tips Market was valued at USD 98.4 Million in 2022 and it is anticipated to grow up to USD 315.9 Million by 2032, at a CAGR of 12.4% during the forecast period. Pipette Tips are disposable,… Read More
Single User License
Buy Now

Mucopolysaccharidosis – Drug Pipeline Landscape, 2023
January, 2023

Mucopolysaccharidosis is a group of metabolic inherited lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, a lysosomal enzyme normally required for the breakdown of certain complex carbohydrates known as glycosaminoglycans (GAGs). There are seven types of mucopolysaccharidosis : mps… Read More
Single User License
Buy Now

Social Anxiety Disorder (SAD) – Drug Pipeline Landscape, 2023
January, 2023

Social Anxiety Disorder is a significant and persistent fear of social and performance-related situations it is one of the most common mental disorders. Social Anxiety Disorder is caused by the complex interaction of biological and environmental factors like inherited traits,… Read More
Single User License
Buy Now

Rabeprazole Sodium Market
January, 2023

The global rabeprazole sodium market was valued at USD 615.7 billion in 2022 and it is anticipated to grow further till USD 984 million by 2032, at a CAGR of 4.8% during the forecast period. Rabeprazole is used to treat… Read More
Single User License
Buy Now